SHP

"Shire, the hyperactivity drug specialist, was up 15p at £10.15 amid talk of a bid for it. AstraZeneca, up 8p at £20.07, has been spoken of as a potential predator in the past. However, Shire directors’ buying of shares after stronger than expected sales of its Vyvanse drug this week indicate that no approach has yet been made."

http://business.timesonline.co.uk/tol/business/markets/article3442023.ece